The aim of this study is to evaluate the analgesic and anti-inflammatory effects of photobiomodulation in participants undergoing dental implant placement. A randomized clinical trial was conducted with 62 participants requiring dental implant placement, divided into two groups of 31 each. Immediately after implant placement, one group received diode laser photobiomodulation, while the SHAM group received sham treatment. Pain and inflammation were assessed at 24 h, 48 h, and 7 days. In addition, Modified Dental Anxiety (MDA) levels were measured and the Oral Health Impact Profile-14 (OHIP-14) questionnaire was used to assess oral health-related quality of life.
Low-Level Laser Therapy (LLLT) has revolutionized medicine, promoting the healing and regeneration of tissues in an innovative way. This study focuses on evaluating the powerful analgesic and anti-inflammatory effects of LLLT in patients undergoing dental implant placement. Methodology A randomized clinical trial was conducted with 62 patients, divided into two groups of 31 each. One group received photobiomodulation with a combined 630 and 808 nm diode laser, while the SHAM group received a simulated treatment. Inclusion criteria: Participants who needed dental implant rehabilitation and signed the informed consent. Participants with a poor general health status, decompensated chronic diseases (diabetes) , pregnant women, and those with bleeding disorders were excluded. Procedure: Informed consent, data collection, complete clinical and oral evaluation, and radiological study with CBCT. Surgical intervention: Placement of dental implants. In the experimental group, low-level laser therapy (LLLT) was applied immediately after the placement of the implants in a single session with an EPIC X Biolase diode laser (BIOLASE, Inc., USA), voltage 100-240 V, 1.5 A, power 0.5 W, 10-20 J, for 10-30 seconds. It was applied to three points in the area: buccal side, palatal/lingual side, and occlusal side to stimulate the tissue. Pain and inflammation were evaluated using visual analog scales (VAS) from day 0 to 7 days postoperatively. Additionally, MDA levels were measured and the OHIP-14 questionnaire was used to assess oral health-related quality of life
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
60
After implant surgery, laser therapy (LLLT) was applied a single session with an EPIC X Biolase diode laser (BIOLASE, Inc., USA)
After implant surgery, After implant surgery, laser therapy (LLLT) was applied in the same manner but without activating it
Pia Lopez Jornet
Murcia, Spain
Pain levels assessed with the visual analogue scale (VAS)
A score of 0 indicated no pain while 10 indicated the worst pain possible
Time frame: 24h-48h,7 days
inflammation evels assessed with the visual analogue scale
A score of 0 indicated no inflammation while 10 indicated the worst inflammation possible
Time frame: 24h-48h,7 days
Modified Corah Dental Anxiety Scale (MDAS)
(0 relaxed, 1 slightly anxious, 2 quite anxious, 3 very anxious or 4 extremely anxious). The total sum was obtained and 4 ranges of fear and anxiety were established (\<9 mild or no anxiety, 9-12 moderate anxiety, 13-14 high anxiety, \>14 phobic anxiety, \>14 very anxious anxiety, \>14 very anxious anxiety, \>14 very anxious anxiety, \>14 very anxious anxiety, \>14 very anxious anxiety).
Time frame: at day 0 and 7 days
OHIP-14sp
consists of 14 questions related to different dimensions of the patient's quality of life (functional limitation, pain, psychological problems, etc.) higher score worse quality of life
Time frame: at 0 and at 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.